Progressive Supranuclear Palsy: What We Need to Know and What are the Treatment Options for this Neurological Disorder
Author(s): Reema A Sharaf*
Abstract
Progressive Supranuclear Palsy (PSP) is a rare brain disorder. Treatment of patients with PSP is both effective and beneficial. This case review aims to share our experience with active management of PSP, considering the patient, family, and medical context in which the disease occurs. There are many opportunities to help your patients, improve their symptoms, reduce their risk, and harm, and guide them through the complex medical, social, and legal minefields that characterize life with chronic neurological conditions. We summarize the challenges of early diagnosis, consider PSP mimics, and the role of investigations in excluding these, and discuss the available pharmacological and non-pharmacological treatment strategies to tackle the common and challenging symptoms of PSP. The best treatment for PSP should be patient-centered and involve a multidisciplinary team.